Berwick DM, Hackbarth AD. Eliminating waste in US health care. JAMA. 2012;307(14):1513–6.
Porter ME, Teisberg E. How physicians can change the future of health care. JAMA. 2007;297(10):1103–11.
Palmer S, Torgerson DJ. Definitions of efficiency. BMJ. 1999;318(7191):1136.
Eijkenaar F. Pay for performance in health care an international overview of initiatives. Med Care Res Rev. 2012;69(3):251–76.
Eijkenaar F, Emmert M, Scheppach M, Schöffski O. Effects of pay for performance in health care: a systematic review of systematic reviews. Health Policy. 2013;110(2–3):115–30. Review of the current state of knowledge of pay-for-performance schemes summarising the current lack of knowledge about the success of these type of financial incentives. There is an attempt to highlight the features of schemes that have been successful.
Berwick DM. A primer on leading the improvement of systems. BMJ. 1996;312(7031):619–22.
Hibbard JH, Stockard J, Tusler M. Does publicizing hospital performance stimulate quality improvement efforts? Health Aff (Millwood). 2003;22(2):84–94.
Marshall MN, Shekelle PG, Davies HTO, Smith PC. Public reporting on quality in the United States and the United Kingdom. Health Aff (Millwood). 2003;22(3):134–48.
Frølich A, Talavera JA, Broadhead P, Dudley RA. A behavioral model of clinician responses to incentives to improve quality. Health Policy. 2007;80(1):179–93.
Oliver A. Incentivising improvements in health care delivery. Health Econ Policy Law. 2015;10(03):327–43.
Centre H and SCI. Quality and outcomes framework [Internet]. Health and Social Care Information Centre, 1 Trevelyan Square, Boar Lane, Leeds, LS1 6AE, United Kingdom; 2015 [cited 2015 Nov 23]. Available from: http://www.hscic.gov.uk/qof.
Harrison MJ, Dusheiko M, Sutton M, Gravelle H, Doran T, Roland M. Effect of a national primary care pay for performance scheme on emergency hospital admissions for ambulatory care sensitive conditions: controlled longitudinal study. BMJ. 2014;349(nov11 1):g6423.
Walker S, Mason AR, Claxton K, Cookson R, Fenwick E, Fleetcroft R, et al. Value for money and the Quality and Outcomes Framework in primary care in the UK NHS. Br J Gen Pract. 2010;60(574):e213–20.
Kmietowicz Z. New GP contract: modernisation or miscalculation? BMJ. 2006;333(7580):1192.
Gibofsky A, Harrington JT. Pay for performance in rheumatology: will we get the carrot or the stick? Arthritis Care Res. 2008;59(9):1203–6.
Desai SP, Yazdany J. Quality measurement and improvement in rheumatology: rheumatoid arthritis as a case study. Arthritis Rheum. 2012;63(12):3649–60.
Rheumatology AC of. RISE FAQs [Internet]. 2015 [cited 2015 Dec 2]. Available from: http://www.rheumatology.org/I-Am-A/Rheumatologist/Registries/RISE/RISE-FAQs.
Association AM. 2015 Physician Quality Reporting System (PQRS) measure specifications manual for claims and registry reporting of individual measures. 2014.
Curtis JR, Sharma P, Arora T, Bharat A, Barnes I, Morrisey MA, et al. Physicians’ explanations for apparent gaps in the quality of rheumatology care: results from the US Medicare Physician Quality Reporting System. Arthritis Care Res. 2013;65(2):235–43. Offers insights into the reasons why physicians might not deliver optimal care on the measures collected by the Physician Quality Reporting System (PQRS). The measures collected by the PQRS will be a key component of the Value Based Payment Modifier under the Affordable Care Act.
Primary Care Domain, Health and Social Care Information Centre. Quality and outcomes framework—prevalence, achievements and exceptions report: England, 2013–14. 2015.
Prescribing and Primary Care Team, Health and Social Care Information Centre. Quality and outcomes framework: achievement, prevalence and exceptions data, 2012/13. Vol. V1.0. 2013.
Prescribing and Primary Care Services H and SCIC. Quality and outcomes framework – prevalence, achievements and exceptions report: England, 2013–14. 2014.
NHS England. 2014/15 GMS Contract Negtoiations [Internet]. 2013. Available from: file:///Z:/Incentives%20in%20rheumatology/RA%20Removal/gms-contr-let-at113.pdf.
DeWitt E, Glick HA, Albert DA, Joffe MM, Wolfe F. MEdicare coverage of tumor necrosis factor α inhibitors as an influence on physicians’ prescribing behavior. Arch Intern Med. 2006;166(1):57–63.
Doshi JA, Li P, Puig A. Impact of the medicare modernization act of 2003 on utilization and spending for medicare part B–covered biologics in rheumatoid arthritis. Arthritis Care Res. 2010;62(3):354–61.
Bombardier C, Mian S. Quality indicators in rheumatoid arthritis care: using measurement to promote quality improvement. Ann Rheum Dis. 2013;72 suppl 2:ii128–31.
Harrington JT. Quality of care in rheumatic diseases: performance measures and improvement. Curr Opin Rheumatol. 2008;20(2):153–8.
Carli C, Bridges JFP, Ask J, Lindblad S, Register for the SRA. Charting the possible impact of national guidelines on the management of rheumatoid arthritis. Scand J Rheumatol. 2008;37(3):188–93.
Harrold LR, Harrington JT, Curtis JR, Furst DE, Bentley MJ, Shan Y, et al. Prescribing practices in a US cohort of rheumatoid arthritis patients before and after publication of the American College of Rheumatology treatment recommendations. Arthritis Rheum. 2012;64(3):630–8.
Adhikesavan LG, Newman ED, Diehl MP, Wood GC, Bili A. American college of rheumatology quality indicators for rheumatoid arthritis: benchmarking, variability, and opportunities to improve quality of care using the electronic health record. Arthritis Care Res. 2008;59(12):1705–12.
DeMaria L, Acelajado MC, Luck J, Ta H, Chernoff D, Florentino J, et al. Variations and practice in the care of patients with rheumatoid arthritis: quality and cost of care. J Clin Rheumatol. 2014;20(2):79–86. Study identifying variations in quality and cost of rheumatology service provision in the US. Highlights opportunities for cost control, quality improvement and greater efficiency.
Deal CL, Hooker R, Harrington T, Birnbaum N, Hogan P, Bouchery E, et al. The United States rheumatology workforce: supply and demand, 2005–2025. Arthritis Rheum. 2007;56(3):722–9.
Harrison MJ, Morley KD, Symmons DPM. Developments in rheumatology consultant manpower provision: the BSR/arc Workforce Register 2003–05. Rheumatology. 2006;45(11):1416–21.
Harrison MJ, Deighton C, Symmons DPM. An update on UK rheumatology consultant workforce provision: the BSR/ARC Workforce Register 2005–07: assessing the impact of recent changes in NHS provision. Rheumatology. 2008;47(7):1065–9.
Harrison MJ, Lee S, Deighton C, Symmons DP. UK rheumatology consultant workforce provision 2007–9: results from the BSR/Arthritis Research UK Consultant Workforce Register. Clin Med. 2011;11(2):119–24.
Turner G, Symmons D, Bamji A, Palferman T. Consultant rheumatology workforce in the UK: changing patterns of provision 1997–2001. Rheumatology. 2002;41(6):680–4.
QOF Advisory Committee. QOF Indicator Assessment Report—Advice for NHS England [Internet]. National Institute for Health and Care Excellence; 2013 [cited 2015 Dec 21]. Available from: https://www.nice.org.uk/media/default/Get-involved/Meetings-In-Public/QOF-Advisory-Committee/QOF-indicator-assessment-report-18-September-2013.pdf.
Guthrie B, Morales DR. What happens when pay for performance stops? BMJ. 2014;348:g1413.
Cush JJ. Biological drug use: US perspectives on indications and monitoring. Ann Rheum Dis. 2005;64 Suppl 4:iv18–23
Schneider EC, Epstein AM. Use of public performance reports: a survey of patients undergoing cardiac surgery. JAMA. 1998;279(20):1638–42.
The World Bank. Health expenditure, total (% of GDP) [Internet]. [cited 2016 May 3]. Available from: http://data.worldbank.org/indicator/SH.XPD.TOTL.ZS.
Dhalla I. Canada’s health care system and the sustainability paradox. Can Med Assoc J. 2007;177(1):51–3.